CIK 0001438533
- Large accelerated filer
Travere Therapeutics, Inc.
Sign in to watch- Ticker
- TVTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 262383102
- Phone
- +1 888-969-7879
- Business address
- 3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
- Former names
- Retrophin, Inc., Desert Gateway, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $79,495,607
- in 10 filings, $79.5M under 10b5-1 plans
Net −$79,495,607. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Dube Eric M −$38.5M CHIEF EXECUTIVE OFFICER sold 60% of stake
- Heerma Peter −$17.9M EVP, CHIEF COMMERCIAL OFFICER sold 71% of stake
- ROTE WILLIAM E. −$13.1M Chief Research Officer sold 68% of stake
- Cline Christopher R. −$3.2M CHIEF FINANCIAL OFFICER sold 37% of stake
- Inrig Jula −$2.8M EVP, Head of R&D & CMO sold 31% of stake
Reading 20 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-11-17 | Clague Laura Chief Financial Officer | Grant or award · Employee stock option (right to buy) | +100,000 | 100,000 | ||
| 2014-11-14 | Shkreli Martin Fmr Officer Dir 10% Sharehldr | Sale | −100,000 | $10.23 | $1.0M | 2,837,168 |
| 2014-11-06 | Richardson Steven Gary Director | Grant or award | +20,000 | 122,065 | ||
| 2014-11-06 | Richardson Steven Gary Director | Grant or award · Employee Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2014-11-06 | Golding Cornelius E Director | Grant or award | +20,000 | 23,000 | ||
| 2014-11-06 | Golding Cornelius E Director | Grant or award · Employee Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2014-11-06 | ASELAGE STEVE Chief Executive Officer | Grant or award | +100,000 | 361,756 | ||
| 2014-11-06 | ASELAGE STEVE Chief Executive Officer | Grant or award · Employee Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2014-10-08 | Meckler Jeffrey A Director | Grant or award | +20,000 | 20,000 | ||
| 2014-10-08 | Meckler Jeffrey A Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2014-10-08 | LYONS GARY A Director | Grant or award | +20,000 | 20,000 | ||
| 2014-10-08 | LYONS GARY A Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2014-10-02 | Shkreli Martin Chief Executive Officer | Other acquisition | +332,980 | 2,995,148 | ||
| 2014-10-01 | Shkreli Martin Chief Executive Officer | Purchase | +25,000 | $8.11 | $203K | 2,962,168 |
| 2014-10-01 | Shkreli Martin Chief Executive Officer | Sale | −300,000 | $0.01 | $3K | 2,662,168 |
| 2014-09-30 | Shkreli Martin Chief Executive Officer | Purchase | +4,000 | $9.42 | $38K | 2,937,168 |
| 2014-09-22 | Shkreli Martin Chief Executive Officer | Purchase | +35,000 | $10.82 | $379K | 2,933,168 |
| 2014-09-19 | Shkreli Martin Chief Executive Officer | Purchase | +18,000 | $11.78 | $212K | 2,898,168 |
| 2014-09-17 | Shkreli Martin Chief Executive Officer | Purchase | +6,000 | $11.46 | $69K | 2,880,168 |
| 2014-09-16 | Shkreli Martin Chief Executive Officer | Purchase | +7,500 | $10.69 | $80K | 2,874,168 |
Page 57 of 59 · 1,174 trades